News
PRONOVA PARTNERS WITH HHTC TO ENHANCE SC360 WITH SUPERCONDUCTING CYCLOTRON
June 6, 2024, Maryville, Tennessee, USA
ProNova Solutions, LLC, (ProNova) a US medical device manufacturer committed
to revolutionizing oncology solutions with the most advanced proton therapy
system in the world, and Holistic Health Technology Corporation (HHTC), a
private equity firm with a focus on cancer related innovations announce today
that they have entered into a strategic partnership, pursuant to which ProNova
Solutions will develop and launch the Superconducting Isochronous Cyclotron
(SCIC) for commercialization as an integral component of the SC360 proton
therapy system.
Sharing a
vision to make proton therapy more accessible to cancer patients worldwide,
HHTC and ProNova are collaborating to develop an ultra-compact,
high-performance, and economically efficient proton therapy system. This partnership leverages ProNova’s
innovative proton treatment technology and HHTC’s expertise in finance and
supply chain management for precision machining and semiconductor
manufacturing.
"HHTC
and ProNova are aligned
in their mission and purpose to enhance the health and welfare of cancer
patients," said Alex Lin, Founder and CEO of HHTC. "We are thrilled
to collaborate with ProNova. By combining our strengths in R&D, capital
resources, affiliated proton treatment centers and high-tech industries such as
semiconductor manufacturing, artificial intelligence, and precision machining,
we aim to support ProNova in their mission to expand proton therapy use around
the world."
The ProNova SC360
has successfully treated over 2,000 patients with three treatment rooms at the Tennessee Oncology Proton Center in Nashville, TN, USA. The SCIC will be
integrated into the FDA-approved and clinically demonstrated ProNova SC360 to provide up to a 1000 nA high-current beam, that supports rapid
hypofractionation, breath-hold treatments and clinical FLASH deliveries. The patient-centric SC360 will offer an
improved and distinguished comprehensive proton therapy system, infused with the latest AI-empowered capabilities, including the SCIC cyclotron and a 360o
superconducting gantry capable of Arc therapy.
“The SC360 is a major breakthrough in our fight against cancer and out-delivers
any other proton therapy system in the world, with precise, on-demand dosage
treatments, less collateral damage, higher operational efficiencies and
clinical value,” says Moataz Karmalawy, President, and CEO of ProNova Solutions.
About ProNova
Solutions, LLC
ProNova Solutions, a US medical device manufacturer and subsidiary of Provision Healthcare, was founded in 2011, to create the most innovative proton therapy technology without compromise to the patient.
About Holistic Health
Technology Corporation
HHTC’s mission is to contribute to a comprehensive portfolio of cutting-edge cancer screening technology, particle therapy, and regenerative medicine (the “H2Solutions”).
Contacts:
Nancy Howard, ProNova
Solutions: Email
James Lin, HHTC: Email